Christmas greeting
As the year comes to a close, our shirts quietly celebrate the science behind our achievements. Each discovery was fueled by creativity, teamwork, and your invaluable contributions. We truly appreciate the diverse and meaningful interactions with clinicians, (basic) scientists, patients, and industry partners.
Thank you for joining us on this exciting journey!
Image-based ocular PT planning
Anna and Lennart broke new ground by developing a method for precise, image-based, eye modelling in ocular proton therapy. They are now showcasing its clinical impact through a large retrospective study. Even better: these tools are freely available in the pyROT library. Explore, experiment, and join the #OpenScience movement!
Ocular MRI
Iris delivered quantitative MRI studies on various intraocular tumours. She’s also driving the certification of our multi-channel eye coil, a milestone that will unlock entirely new imaging possibilities.
Visual optics
Corné launched Visisipy, an open-source platform for optical eye simulations; and yes, you can run it straight from your browser! He also developed techniques to fuse fundus photographs with MRI, now being validated across multiple ocular proton therapy centers.
Cone-beam CT development
Innovation in action: our team acquired a uniquely adapted dental cone-beam CT scanner tailored for orbital imaging. Nadine and Arjon, in collaboration with Medcom and Trident, are pushing boundaries to deliver crystal-clear images of the eye and surrounding structures.
Clinical evaluations
Khanh and our clinical team achieved remarkable milestones this year: analyzing outcomes for 700+ consecutive Ruthenium brachytherapy patients and the first 170 ocular proton therapy cases at HollandPTC. These insights are shaping the future of eye cancer care.
Clipless ocular PT
A bold vision is becoming reality: clipless ocular proton therapy. Martijn and Lisa launched the COPTER study to prospectively evaluate our new workflow: a leap forward after years of dedicated development!
Pact4eye
This year, our clinic contributed to numerous clinical trials for both primary and metastatic uveal melanoma, reinforcing our commitment to advancing patient care. Within the Pact4Eye project, Louise played an important role in developing an entirely new treatment approach.
And much more
And that’s not all: we explored the fascinating phenomenon of blue light perception during treatment, created 3D statistical eye models, demonstrated how peripheral refraction influences myopia progression, and shared knowledge through patient advocacy events. These achievements reflect the energy and innovation driving our team forward, and there’s much more to come!